drugset / Trial / NCT05507476

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

NCT05507476

Completed 52 enrolled Zagazig University
RandomizedParallel-groupDouble-blindPrevention

Summary

Dacryocystorhinostomy aims to create a channel between the lacrimal sac and nasal mucosa to relieve nasolacrimal duct occlusion. General anesthesia is still preferred by many surgeons to secure the airway and control blood pressure.

Timeline

Start
2022-09-01
Primary completion
2023-06-01
Completion
2023-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desmopressin Peptide 20 ug Intranasal
Comparator Epinephrine Other / unclassified Intranasal

Indications

No indication recorded.